HIV-HCV Coinfection: Prevalence and Treatment Outcomes in Malaysia

Intervirology · Published 2021-08-26 · DOI 10.1159/000518836

Authors being retrieved — see the publisher record. https://doi.org/10.1159/000518836

Abstract

PubPorta does not have an abstract for this article yet.

Read the article at the publisher →

Publication details

Year

2021

Related articles

• Polygenic risk score and risk of drug-induced liver injury after initiating antiretroviral therapy in people living with HIV · PHARMACOGENOMICS · 2026 · Cites or is cited by this article
• Acknowledgement to Reviewers · Intervirology · 2025 · Same journal
• SARS-COV-2 Triggers the Development of Class I and Class II HLA Antibodies in Recovered Convalescent Plasma Donors · Intervirology · 2022 · Same journal
• Global prevalence of pre-existing antibodies against human adenoviruses, surveyed from 1962-2021 · Intervirology · 2024 · Same journal
• Hepatitis E Virus Capsid as a Carrier of Exogenous Antigens for the Development of Chimeric Virus-Like Particles · Intervirology · 2021 · Same journal
• Comparison of a Multiplex Real-Time PCR Technique with Oxford Nanopore Technologies Next-Generation Sequencing for Identification of SARS-CoV-2 Variants of Concern · Intervirology · 2023 · Same journal
• Evaluation of Sandwich Enzyme-Linked Immunosorbent Assay and Reverse Transcription Polymerase Chain Reaction for the Diagnosis of Foot-and-Mouth Disease · Intervirology · 2021 · Same journal
• Low-Intensity Ultrasound as a Novel Strategy to Improve the Cytotoxic Effect of Oncolytic Reovirus on Colorectal Cancer Model Cells · Intervirology · 2021 · Same journal
• Structures of SARS-CoV-2 RNA-Binding Proteins and Therapeutic Targets · Intervirology · 2021 · Same journal
• Identification and Verification of Ubiquitin D as a Gene Associated with Hepatitis C Virus-Induced Hepatocellular Carcinoma · Intervirology · 2022 · Same journal